Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cellular Injury I: Introduction01:00

Cellular Injury I: Introduction

Cellular injury occurs when a cell cannot maintain homeostasis or adapt to stressors such as hypoxia, toxins, or trauma. Depending on severity and duration, injury may be reversible, allowing recovery, or irreversible, leading to cell death.General Mechanisms of Cell InjuryAlthough causes vary, most cellular injuries arise from a few key mechanisms that disrupt essential functions and often amplify one another. Cell survival depends on the extent and balance of these disturbances.ATP depletion...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial.

European heart journal·2021
Same author

Efficacy of thromboelastography in the management of anticoagulation for veno-venous extracorporeal membrane oxygenation in a coronavirus disease 2019 patient: A case report.

Medicine·2021
Same author

JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias.

Circulation journal : official journal of the Japanese Circulation Society·2021
Same author

Beta-Blocker Use Is Associated With Prevention of Left Ventricular Remodeling in Recovered Dilated Cardiomyopathy.

Journal of the American Heart Association·2021
Same author

Nanoparticle-Mediated Simultaneous Targeting of Mitochondrial Injury and Inflammation Attenuates Myocardial Ischemia-Reperfusion Injury.

Journal of the American Heart Association·2021
Same author

Activation of Invariant Natural Killer T Cells by α-Galactosylceramide Attenuates the Development of Angiotensin II-Mediated Abdominal Aortic Aneurysm in Obese <i>ob/ob</i> Mice.

Frontiers in cardiovascular medicine·2021

Related Experiment Video

Updated: May 29, 2026

Analysis of Oxidative Stress in Zebrafish Embryos
11:05

Analysis of Oxidative Stress in Zebrafish Embryos

Published on: July 7, 2014

Oxidative stress and heart failure.

Hiroyuki Tsutsui1, Shintaro Kinugawa, Shouji Matsushima

  • 1Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan. htsutsui@med.hokudai.ac.jp

American Journal of Physiology. Heart and Circulatory Physiology
|September 28, 2011
PubMed
Summary

Oxidative stress, caused by excess reactive oxygen species (ROS), drives heart failure (HF) by damaging heart and skeletal muscles. Understanding these mechanisms is key to developing new therapies for HF.

More Related Videos

Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors
09:33

Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors

Published on: February 7, 2018

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets
06:35

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets

Published on: March 29, 2024

Related Experiment Videos

Last Updated: May 29, 2026

Analysis of Oxidative Stress in Zebrafish Embryos
11:05

Analysis of Oxidative Stress in Zebrafish Embryos

Published on: July 7, 2014

Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors
09:33

Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors

Published on: February 7, 2018

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets
06:35

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets

Published on: March 29, 2024

Area of Science:

  • Cardiology
  • Biochemistry
  • Pathophysiology

Background:

  • Oxidative stress, an imbalance between reactive oxygen species (ROS) and antioxidant defenses, is critical in heart failure (HF).
  • ROS, originating from sources like mitochondria, induce cellular dysfunction and damage at elevated levels.
  • In failing hearts, mitochondrial ROS production increases while antioxidant enzyme activity remains normal.

Purpose of the Study:

  • To elucidate the role of oxidative stress in cardiac remodeling and heart failure.
  • To explore the mechanisms by which ROS contribute to myocardial and skeletal muscle dysfunction in HF.
  • To identify potential therapeutic targets for HF based on oxidative stress pathways.

Main Methods:

  • Review of existing literature on oxidative stress and heart failure.
  • Analysis of intracellular ROS sources and their impact on cellular pathways.
  • Examination of ROS-mediated effects on cardiac contractile function, hypertrophy signaling, apoptosis, and extracellular matrix remodeling.
  • Investigation of oxidative stress involvement in skeletal muscle dysfunction associated with HF.

Main Results:

  • Oxidative stress triggers maladaptive cardiac remodeling and HF progression.
  • ROS directly impair cardiac contractility and activate pro-hypertrophy and pro-apoptotic pathways.
  • ROS stimulate cardiac fibroblast proliferation and matrix metalloproteinase activity, leading to extracellular matrix remodeling.
  • Oxidative stress contributes to skeletal muscle dysfunction, exercise intolerance, and insulin resistance in HF patients.

Conclusions:

  • Oxidative stress is a significant factor in the pathophysiology of both cardiac and skeletal muscle dysfunction in heart failure.
  • ROS-induced damage to cellular components and signaling pathways drives HF progression.
  • Targeting oxidative stress pathways presents a promising strategy for novel therapeutic interventions against heart failure.